EUVIMEDEUVIMED entdecken
Crossref

Biological variation estimates of laboratory assays for von Willebrand disease, including von Willebrand factor activity using VWF:GPIbM

Róisín Spriggs, Lorna Power, Maeve P Crowley, James V Harte

Clinica Chimica Acta · 2026-11 · 122963

DOI: 10.1016/j.cca.2026.122963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2026-11. Verfasst von Róisín Spriggs und 3 weiteren Autor:innen. Beteiligte Einrichtung: EOLAS Research Group, Cork University Hospital, Wilton, Cork, Ireland; Department of Haematology, Cork University Hospital, Wilton, Cork, Ireland. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimates of biological variation (BV) provide an important basis for establishing performance specifications. However, BV data for haemostasis measurands remain limited, particularly for laboratory assays used in the investigation of investigation and diagnosis of von Willebrand disease (VWD). As such, we study aimed to estimate the variation associated with VWF and FVIII measurands and to derive BV-based performance specifications. Fourteen healthy adults were sampled weekly for four consecutive weeks. VWF antigen (VWF:Ag), VWF activity (VWF:Ac) - including ristocetin cofactor activity (VWF:RCo) and gain-of-function mutant GPIb activity (VWF:GPIbM) - and FVIII coagulant activity (FVIII:C) were measured on a Sysmex CN3500 analyser (Kobe Japan). Data were analysed using the recently developed BV Calculator to estimate analytical (CVA), within subject (CVI) and between-subject (CVG) variations. Reference change values and analytical performance specifications were also subsequently derived. The estimated CVI and CVG were 5.9% (95% CI, 4.8-7.5%) and 26.8% (19.2-44.7%) for VWF:Ag; 9.5% (7.6-12.4%) and 34.6% (24.5-58.9%) for VWF:RCo; 5.2% (4.3-6.8%) and 33.7% (24.0-56.9%) for VWF:GPIbM; and 9.9% (8.1-12.7%) and 20.5% (14.3-34.2%) for FVIII:C, respectively. CVI estimates were generally lower than corresponding meta-analysis estimates for VWF:Ag and both VWF:Ac assays, whereas the CVI estimate for FVIII:C was broadly comparable. Consequently, the derived specifications were generally more stringent than those based on existing estimates. This study provides additional estimates of BV for laboratory assays used in the investigation of VWD, including VWF:GPIbM - which have not been previously published. Further studies are warranted to assess the generalisability of these estimates.

Schlagwörter

Stichwörter der Autor:innen

BIVACBV calculatorBiological variationEuBIVASvon Willebrand diseasevon Willebrand factor

Autor:innen und Institutionen

  • EOLAS Research Group, Cork University Hospital, Wilton, Cork, Ireland; Department of Haematology, Cork University Hospital, Wilton, Cork, Ireland.
  • Department of Haematology, Cork University Hospital, Wilton, Cork, Ireland.
  • EOLAS Research Group, Cork University Hospital, Wilton, Cork, Ireland; Department of Haematology, Cork University Hospital, Wilton, Cork, Ireland; School of Medicine, University College Cork, Cork, Ireland.
  • EOLAS Research Group, Cork University Hospital, Wilton, Cork, Ireland; Department of Haematology, Cork University Hospital, Wilton, Cork, Ireland; Department of Biological Sciences, Munster Technological University, Cor…

Zitieren

APA

Spriggs, R., Power, L., Crowley, M. P., & Harte, J. V. (2026). Biological variation estimates of laboratory assays for von Willebrand disease, including von Willebrand factor activity using VWF:GPIbM. Clinica Chimica Acta, 122963. https://doi.org/10.1016/j.cca.2026.122963

Vancouver

Spriggs R, Power L, Crowley MP, Harte JV. Biological variation estimates of laboratory assays for von Willebrand disease, including von Willebrand factor activity using VWF:GPIbM. Clinica Chimica Acta. 2026:122963. doi:10.1016/j.cca.2026.122963

BibTeX
@article{Spriggs2026,
  author = {Spriggs, Róisín and Power, Lorna and Crowley, Maeve P and Harte, James V},
  title = {Biological variation estimates of laboratory assays for von Willebrand disease, including von Willebrand factor activity using VWF:GPIbM},
  journal = {Clinica Chimica Acta},
  year = {2026},
  pages = {122963},
  doi = {10.1016/j.cca.2026.122963}
}
Kostenlos starten →